The purpose of this study is to confirm the safety profile / factors which impact safety and
efficacy of Nexium capsules in daily clinical usage for the patients who have been
prescribed Nexium for "gastric ulcer", "duodenal ulcer", "anastomotic ulcer", "reflux
oesophagitis", "non-erosive reflux disease", or "Zollinger-Ellison syndrome"
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Research Site, Aichi, Japan
Research Site, Akita, Japan
Research Site, Aomori, Japan
Research Site, Chiba, Japan
Research Site, Ehime, Japan
Research Site, Fukui, Japan
Research Site, Fukuoka, Japan
Research Site, Fukushima, Japan
Research Site, Gifu, Japan
Research Site, Gunma, Japan
Research Site, Hiroshima, Japan
Research Site, Hokkaido, Japan
Research Site, Hyogo, Japan
Research Site, Ibaraki, Japan
Research Site, Ishikawa, Japan
Research Site, Iwate, Japan
Research Site, Kagawa, Japan
Research Site, Kagoshima, Japan
Research Site, Kanagawa, Japan
Research Site, Kochi, Japan
Research Site, Kumamoto, Japan
Research Site, Kyoto, Japan
Research Site, Mie, Japan
Research Site, Miyagi, Japan
Research Site, Miyazaki, Japan
Research Site, Nagano, Japan
Research Site, Nagasaki, Japan
Research Site, Nara, Japan
Research Site, Niigata, Japan
Research Site, Oita, Japan
Research Site, Okayama, Japan
Research Site, Okinawa, Japan
Research Site, Osaka, Japan
Research Site, Saga, Japan
Research Site, Saitama, Japan
Research Site, Shiga, Japan
Research Site, Shimane, Japan
Research Site, Shizuoka, Japan
Research Site, Tochigi, Japan
Research Site, Tokushima, Japan
Research Site, Tokyo, Japan
Research Site, Tottori, Japan
Research Site, Toyama, Japan
Research Site, Wakayama, Japan
Research Site, Yamagata, Japan
Research Site, Yamaguchi, Japan
Research Site, Yamanashi, Japan